Research shows NAD+ inhibits KDM5a, preserving immune memory in mouse and human cells — Evidence Review
Published in Science Immunology, by researchers from Radboud Institute for Molecular Life Sciences
Table of Contents
A new study reveals that the immune system preserves its “memory” of past threats by using NAD+ to inhibit an epigenetic eraser enzyme, helping immune cells stay primed for rapid response. Related research largely supports these findings, highlighting the interplay between metabolic and epigenetic mechanisms in immune memory, though some nuances in human data and disease contexts remain under investigation (1, 6, 7).
- Multiple studies confirm that trained immunity in innate immune cells is mediated through sustained epigenetic and metabolic changes, with NAD+ recognized as a crucial regulator of immune cell function (1, 6, 7).
- The mechanism identified in the new study—NAD+ inhibiting the KDM5a demethylase to maintain inflammatory gene readiness—aligns with recent evidence that chromatin modifications underpin innate immune memory (3, 8, 10).
- While these mechanisms are established in animal and in vitro models, ongoing research is probing their applicability to human immunity, aging, and disease, with both supportive and cautionary findings (4, 6, 7).
Study Overview and Key Findings
Understanding how the immune system “remembers” past encounters is crucial for vaccine development, disease treatment, and explaining age-related immune decline. This study is particularly timely as it addresses a longstanding question: how do innate immune cells retain epigenetic marks needed for trained immunity, despite the presence of enzymes that typically erase such modifications? By focusing on the metabolic-epigenetic interface, the research uncovers a molecular mechanism that may link immunity, cancer defense, and aging, offering important insights beyond standard animal models.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | Radboud Institute for Molecular Life Sciences |
| Journal Name | Science Immunology |
| Authors | Jin, H., Wang, Z., Liu, Y., Wang, Z., Li, M., Xue, J., Zhang, Y., Yu, T., Wang, S., Huo, B., Li, C., Wang, X., Yao, R., Zhang, H., Yi, J., Lin, Y., Cui, L., Guo, H., Guo, Z., Xia, X. |
| Population | Mouse immune cells and human cells in lab dishes |
| Methods | Animal Study |
| Outcome | Mechanisms of immune memory and inflammation response |
| Results | NAD+ inhibits KDM5a, maintaining immune memory in cells. |
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus database of over 200 million research papers using the following queries:
- immune memory epigenetics mechanisms
- NAD+ KDM5a immune system function
- epigenetic changes germ recognition immune cells
Related Studies Table
| Topic | Key Findings |
|---|---|
| How do epigenetic mechanisms contribute to innate immune memory? | - Trained immunity involves stable epigenetic and metabolic reprogramming of innate immune cells (1, 2, 8, 12) - Chromatin accessibility changes “prime” immune cells for rapid gene activation (3, 8, 10) |
| What is the role of NAD+ and metabolic regulation in immune memory? | - NAD+ is essential for immune cell metabolic reprogramming and function (6, 7) - Nuclear NAD+ inhibits KDM5a demethylase, sustaining epigenetic marks that maintain immune memory (7) |
| How do these mechanisms affect disease, aging, and vaccine responses? | - Epigenetic and metabolic changes in immune cells influence responses to infection, cancer, and decline with aging (4, 6, 7) - Vaccines and infections can induce durable epigenetic remodeling in innate immunity (9, 11) |
How do epigenetic mechanisms contribute to innate immune memory?
Research over the past decade has established that innate immune cells, once thought to lack memory, can undergo long-lasting functional changes through epigenetic reprogramming. Multiple studies demonstrate that exposure to pathogens or immune stimuli induces chromatin modifications and transcriptional changes, enabling faster and stronger responses to subsequent challenges (1, 2, 3, 8, 10, 12). The new study builds on this foundation by identifying a specific molecular pathway—NAD+-mediated inhibition of KDM5a—that preserves these epigenetic marks.
- Trained immunity is characterized by sustained histone modifications (such as H3K4me3) and altered chromatin accessibility, allowing innate immune cells to “remember” past encounters (3, 8, 10).
- Epigenetic changes can be durable, even in dividing cell populations, suggesting a mechanism for long-term innate immune memory (1, 12).
- Related studies indicate that both innate and adaptive immune memory rely on chromatin state alterations, but innate memory is non-specific and driven by environmental cues (5, 10).
- The mechanism uncovered in the new study clarifies how such epigenetic marks can persist despite the presence of enzymes that typically remove them (7).
What is the role of NAD+ and metabolic regulation in immune memory?
The intersection of metabolism and epigenetic regulation is a central theme in recent immunological research. NAD+ has emerged as a key metabolite in immune cell function, supporting both energy production and signaling roles. The new study’s finding that nuclear NAD+ directly inhibits KDM5a, a histone demethylase, provides important mechanistic insight into how metabolic changes can stabilize epigenetic memory in immune cells (7). This connection has been anticipated by prior work showing that NAD+ levels and metabolism are closely linked to immune cell activation and differentiation (6).
- NAD+ is required for metabolic reprogramming during immune cell activation, influencing both effector functions and memory (6).
- Inhibition of KDM5a by NAD+ preserves histone methylation marks, maintaining immune cells in a “primed” state (7).
- Depletion of NAD+ impairs trained immunity and reduces anti-tumor responses in animal models (7).
- Supplementation with NAD+ precursors can restore trained immunity in deficient or aged animals, highlighting therapeutic potential (7).
How do these mechanisms affect disease, aging, and vaccine responses?
Epigenetic and metabolic reprogramming of innate immune cells has significant implications for health and disease. Several studies have shown that these mechanisms influence susceptibility to infections, the efficacy of vaccines, the immune response to cancer, and the decline of immune function with age (4, 6, 7, 9, 11). The new study links declining NAD+ with reduced immune memory in aging, and demonstrates that manipulating this pathway can impact cancer immunity.
- Lasting epigenetic changes after infections (e.g., COVID-19) can alter immune responses for months or years, potentially affecting millions of people (4).
- Vaccine-induced epigenetic remodeling can enhance or dampen responses to unrelated pathogens, supporting the concept of heterologous vaccine effects (9, 11).
- The ability to modulate NAD+ and epigenetic marks in immune cells suggests new avenues for treating cancer, autoimmunity, and age-related immune decline (6, 7).
- However, differences between mouse and human immune systems, and between disease contexts, mean that findings require careful validation in clinical settings (4, 7).
Future Research Questions
While the new study advances understanding of metabolic-epigenetic crosstalk in innate immunity, important questions remain about how these mechanisms operate in humans, influence disease outcomes, and can be targeted therapeutically. Further research is needed to clarify the broader impact, safety, and translational potential of these findings.
| Research Question | Relevance |
|---|---|
| How do NAD+-regulated epigenetic mechanisms impact human immune memory across the lifespan? | Understanding age-related changes in NAD+ and epigenetic marks could inform interventions for immunosenescence and vaccine responses in older adults (4, 6, 7). |
| Can NAD+ supplementation or modulation enhance immune function in cancer patients? | Preclinical models suggest potential for NAD+ precursors to restore immune memory and improve anti-tumor activity, but efficacy and safety in humans must be established (6, 7). |
| What are the mechanistic differences in epigenetic immune memory between humans and mice? | Most mechanistic insights come from mouse models; understanding species differences is critical for translating findings to human health and disease (4, 7). |
| How do epigenetic and metabolic reprogramming in innate immunity influence autoimmunity or chronic inflammation? | Epigenetic “priming” may have unintended consequences, such as promoting chronic inflammation or autoimmunity, which needs investigation for safe therapeutic targeting (1, 6, 10). |
| Can targeting NAD+ or KDM5a improve vaccine efficacy or response breadth? | Manipulating these pathways may boost non-specific vaccine effects and cross-protection, but optimal strategies and risks must be defined (9, 11). |
This comprehensive review highlights how the new study fits into and advances the broader scientific understanding of immune memory, epigenetics, and metabolism. While the findings are robust and broadly supported by related research, further work is required to translate these insights into human health applications and to clarify their implications across diverse diseases and populations.